We used comparative transcriptomics to test correlation of CHRNA5 RNAi expression signature in MCF7 cells with the expression profiles from CCLE breast cancer cell lines, and from nutlin-3a induced as well as from topoisomerase inhibited MCF7 cells. This evidence concerns the gene CHRNA5 and breast cancer.